Transfusion strategy for acute upper gastrointestinal bleeding.

Area of Science:

• Gastroenterology
• Hematology
• Critical Care Medicine

Background:

• Acute upper gastrointestinal bleeding is a common medical emergency.
• Transfusion strategies aim to improve oxygen delivery but can carry risks.
• Optimal hemoglobin thresholds for red blood cell transfusion in this setting remain debated.

Purpose of the Study:

• To compare patient outcomes between a restrictive hemoglobin transfusion threshold (70 g/L) and a liberal threshold (90 g/L) in acute upper gastrointestinal bleeding.
• To evaluate the impact of transfusion strategy on mortality, re-bleeding rates, and adverse events.

Main Methods:

• Randomized controlled trial involving patients with acute upper gastrointestinal bleeding.
• Patients were assigned to either a 70 g/L or 90 g/L hemoglobin transfusion threshold.
• Primary outcome was 45-day all-cause mortality; secondary outcomes included re-bleeding and adverse events.

Main Results:

• No significant difference in 45-day mortality between the restrictive (70 g/L) and liberal (90 g/L) transfusion groups.
• The restrictive strategy resulted in fewer red blood cell units transfused per patient.
• Rates of further bleeding and adverse events were similar between the groups.

Conclusions:

• A restrictive hemoglobin transfusion threshold of 70 g/L is a safe and effective strategy for patients with acute upper gastrointestinal bleeding.
• This approach can reduce transfusion requirements without compromising patient outcomes.
• Clinical guidelines may consider adopting more restrictive transfusion thresholds in this patient population.